is retatrutide glp 3 Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety Retatrutide Dosage And Protocols -

C., Jos Soler, M., Luis Grriz, J., & Rubio-Herrera, M

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group

To the wellness industry, GLP-1s actual significance doesnt seem to matter nearly as much as its association with thinness

One possibility is that the difference in efficiency in weight loss is due to a higher uptake of liraglutide in the CNS

Long-term effect of weight regain following behavioral weight management programs on cardiometabolic disease incidence and risk: systematic review and meta-analysis

These options are more expensive but come with regulatory assurances that compounded medications do not